All Stories

  1. A magnetic resonance imaging (MRI)-based deep learning radiomics model predicts recurrence-free survival in lung cancer patients after surgical resection of brain metastases
  2. Editorial for “A Glycine‐Targeted In Vivo Magnetic Resonance Spectroscopy for Quantifying Glycine in Glioma”
  3. The diagnostic performance and reader agreement of the Prostate Imaging for Recurrence Reporting system in the evaluation of local recurrence in patients with biochemically recurrent prostate cancer
  4. Artificial intelligence model for automatic 3-dimensional reconstruction of ossicular chain and bony labyrinth from high-resolution CT
  5. Quantification of the Engraftment Status of Mesenchymal Stem Cells in Glioma Using Dual-Modality Magnetic Resonance Imaging and Bioluminescence Imaging
  6. In situ editing of tumour cell membranes induces aggregation and capture of PD-L1 membrane proteins for enhanced cancer immunotherapy
  7. A Multifunctional Nanodrug Increases the Therapeutic Sensitivity of Lenvatinib to Hepatocellular Carcinoma by Inhibiting the Stemness of Hepatic Cancer Stem Cells
  8. Mean Apparent Propagator MRI: Quantitative Assessment of Tumor-Stroma Ratio in Invasive Ductal Breast Carcinoma
  9. Radio- and Photosensitizing Os(II)-Based Nanocage for Combined Radio-/Chemo-/X-ray-Induced Photodynamic Therapies, NIR Imaging, and Drug Delivery
  10. Discrimination between human epidermal growth factor receptor 2 (HER2)-low-expressing and HER2-overexpressing breast cancers: a comparative study of four MRI diffusion models
  11. Comparison of surface microscopy coil and ankle joint special phased array coil magnetic resonance imaging in assessing preoperative osteochondral lesions of the talus
  12. MRI-based Quantification of Intratumoral Heterogeneity for Predicting Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer
  13. Enhanced radiosensitivity and chemoradiation efficacy in nasopharyngeal carcinoma via a dual-targeted SPION@polymer hybrid nanosensitizer
  14. Detecting lesion-specific ischemia in patients with coronary artery disease with computed tomography fractional flow reserve measured at different sites
  15. Data from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  16. Data from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  17. Figure S1 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  18. Figure S1 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  19. Figure S2 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  20. Figure S2 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  21. Figure S3 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  22. Figure S3 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  23. Figure S4 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  24. Figure S4 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  25. Figure S5 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  26. Figure S5 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  27. Figure S6 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  28. Figure S6 from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  29. Supplementary Material from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  30. Supplementary Material from A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  31. The aging of glymphatic system in human brain and its correlation with brain charts and neuropsychological functioning
  32. Context-aware network fusing transformer and V-Net for semi-supervised segmentation of 3D left atrium
  33. The value of quantitative plaque analysis based on coronary computed tomography angiography in predicting the percutaneous coronary intervention outcome of chronic total occlusion lesions
  34. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy
  35. Upconversion NaYF4:Yb/Er–TiO2–Ti3C2 Heterostructure-Based Near-Infrared Light-Driven Photoelectrochemical Biosensor for Highly Sensitive and Selective d-Serine Detection
  36. Upregulating HIF‐1 α to Boost the Survival of Neural Stem Cells via Functional Peptides‐Complexed MRI‐Visible Nanomedicine for Stroke Therapy
  37. ADC and kinetic parameter of primary tumor: Surrogate imaging markers for fertility-sparing vaginal radical trachelectomy in patients with stage IB cervical cancer
  38. Manganese-doped mesoporous polydopamine nanoagent for T1–T2 magnetic resonance imaging and tumor therapy
  39. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy
  40. Upregulating microRNA‐210 to Inhibit Apoptosis of Neural Stem Cells with an MRI–Visible Nanomedicine for Stroke Therapy
  41. Preoperative Prediction of the Aggressiveness of Oral Tongue Squamous Cell Carcinoma with Quantitative Parameters from Dual-Energy Computed Tomography
  42. Manganese Dioxide‐Based Nanocarrier Delivers Paclitaxel to Enhance Chemotherapy against Orthotopic Glioma through Hypoxia Relief
  43. Unimolecular Nano-contrast Agent with Ultrahigh Relaxivity and Very Long Retention for Magnetic Resonance Lymphography
  44. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
  45. Co-existing Hypertension and Hyperhomocysteinemia Increases the Risk of Carotid Vulnerable Plaque and Subsequent Vascular Event: An MR Vessel Wall Imaging Study
  46. Pretreatment DCE-MRI-Based Deep Learning Outperforms Radiomics Analysis in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
  47. Successful combinatorial therapy of sirolimus and neuraminidase inhibitors in a patient with highly pathogenic avian influenza A (H5N6) virus: a case report
  48. MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer
  49. Quantitative Parameters of Diffusion Spectrum Imaging: HER2 Status Prediction in Patients With Breast Cancer
  50. Relationship between lung injury extent and phenotype manifested in non-contrast CT and cardiac injury during acute stage of COVID-19
  51. The ratio of the max-to-mean coronary artery calcium score in the most calcified vessel is associated with the presence of coronary artery disease
  52. IMIIN: An inter-modality information interaction network for 3D multi-modal breast tumor segmentation
  53. Platinum-crosslinking polymeric nanoparticle for synergetic chemoradiotherapy of nasopharyngeal carcinoma
  54. Magnetic resonance neuroimaging promotes the preservation of pelvic autonomic nerves in laparoscopic total mesorectal excision: a comparative study
  55. Development and Validation of a Deep Learning Algorithm to Automatic Detection of Pituitary Microadenoma From MRI
  56. Silencing of Pyruvate Kinase M2 via a Metal–Organic Framework Based Theranostic Gene Nanomedicine for Triple-Negative Breast Cancer Therapy
  57. A coarse‐refine segmentation network for COVID‐19 CT images
  58. The Long-Term Fate of Mesenchymal Stem Cells Labeled with Magnetic Resonance Imaging-Visible Polymersomes in Cerebral Ischemia [Erratum]
  59. Deep Learning Enables Accurate Diagnosis of Novel Coronavirus (COVID-19) With CT Images
  60. Protein-directed, hydrogen-bonded biohybrid framework
  61. Peptide-Modified Nanoparticles for Tumor Targeting and Molecular Imaging
  62. Recent Advances in Strategies and Tools for Efficient Drug Discovery and Delivery - Part II
  63. Author Correction: A deep-learning pipeline for the diagnosis and discrimination of viral, non-viral and COVID-19 pneumonia from chest X-ray images
  64. Altered Posterior Cerebellar Lobule Connectivity With Perigenual Anterior Cingulate Cortex in Women With Primary Dysmenorrhea
  65. Dynamic network topological properties for classifying primary dysmenorrhoea in the pain‐free phase
  66. Pelvic Pain Alters Functional Connectivity Between Anterior Cingulate Cortex and Hippocampus in Both Humans and a Rat Model
  67. Decoupling convolution network for characterizing the metastatic lymph nodes of breast cancer patients
  68. A deep-learning pipeline for the diagnosis and discrimination of viral, non-viral and COVID-19 pneumonia from chest X-ray images
  69. R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions
  70. Radiomics model of dual-time 2-[18F]FDG PET/CT imaging to distinguish between pancreatic ductal adenocarcinoma and autoimmune pancreatitis
  71. Accurately Discriminating COVID-19 from Viral and Bacterial Pneumonia According to CT Images Via Deep Learning
  72. Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer
  73. Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients
  74. Nanomedicine Directs Neuronal Differentiation of Neural Stem Cells via Silencing Long Noncoding RNA for Stroke Therapy
  75. Fluorescent probes for bioimaging of potential biomarkers in Parkinson's disease
  76. Nanofibrous nerve guidance conduits decorated with decellularized matrix hydrogel facilitate peripheral nerve injury repair
  77. Clinical longitudinal evaluation of COVID-19 patients and prediction of organ-specific recovery using artificial intelligence
  78. Iron-Mineralization-Induced Mesoporous Metal–Organic Frameworks Enable High-Efficiency Synergistic Catalysis of Natural/Nanomimic Enzymes
  79. Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models
  80. Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
  81. Bimodal Imaging‐Visible Nanomedicine Integrating CXCR4 and VEGFa Genes Directs Synergistic Reendothelialization of Endothelial Progenitor Cells
  82. Quantitative dynamic contrast-enhanced MR imaging can be used to predict the pathologic stages of oral tongue squamous cell carcinoma
  83. Histological validation of simultaneous non-contrast angiography and intraplaque hemorrhage imaging (SNAP) for characterizing carotid intraplaque hemorrhage
  84. Mean Apparent Propagator MRI Is Better Than Conventional Diffusion Tensor Imaging for the Evaluation of Parkinson’s Disease: A Prospective Pilot Study
  85. Quantitative kinetic parameters of primary tumor can be used to predict pelvic lymph node metastasis in early-stage cervical cancer
  86. LNK deficiency decreases obesity-induced insulin resistance by regulating GLUT4 through the PI3K-Akt-AS160 pathway in adipose tissue
  87. Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis
  88. Pretreatment structural and arterial spin labeling MRI is predictive for p53 mutation in high-grade gliomas
  89. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography
  90. Deep Learning-Based Radiomics of B-Mode Ultrasonography and Shear-Wave Elastography: Improved Performance in Breast Mass Classification
  91. Recent advance on PTP1B inhibitors and their biomedical applications
  92. A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy
  93. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy
  94. One-/Two-Photon Excited Cell Membrane Imaging and Tracking by a Photoactive Nanocage
  95. Discriminative pattern of reduced cerebral blood flow in Parkinson’s disease and Parkinsonism-Plus syndrome: an ASL-MRI study
  96. Aberrant Functional and Causal Connectivity in Acute Tinnitus With Sensorineural Hearing Loss
  97. Discriminative Pattern of Reduced Cerebral Blood Flow in Parkinson's Disease and Parkinsonism-Plus Syndrome: an ASL-MRI study
  98. Cleavable bimetallic-organic polymers for ROS mediated cascaded cancer therapy under the guidance of MRI through tumor hypoxia relief strategy
  99. Metal‐Organic Frameworks: A New Platform for Enzyme Immobilization
  100. Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography
  101. Identification of Specific Joint-Inflammatogenic Cell-Free DNA Molecules From Synovial Fluids of Patients With Rheumatoid Arthritis
  102. “Panzerung” von Enzymen mit Metall‐organischen Gerüsten
  103. “Armor‐Plating” Enzymes with Metal–Organic Frameworks (MOFs)
  104. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure
  105. MR Imaging of Enhanced Nerve Repair with Mesenchymal Stem Cells Combined with Microenvironment Immunomodulation in Neurotmesis
  106. Peritumoral administration of IFNβ upregulated mesenchymal stem cells inhibits tumor growth in an orthotopic, immunocompetent rat glioma model
  107. The Usefulness of Bayesian Network in Assessing the Risk of Triple-Negative Breast Cancer
  108. Discriminative Pattern of Reduced Cerebral Blood Flow in Parkinson's Disease and Parkinsonism-Plus Syndrome: an ASL-MRI study
  109. pH-Sensitive nanotheranostics for dual-modality imaging guided nanoenzyme catalysis therapy and phototherapy
  110. The value of MRI examination on bilateral hands including proximal interphalangeal joints for disease assessment in patients with early rheumatoid arthritis: a cross-sectional cohort study
  111. Spontaneous pneumomediastinum and subcutaneous emphysema in avian influenza A (H5N6) human pneumonia
  112. tLyp-1-conjugated GSH-sensitive biodegradable micelles mediate enhanced pUNO1-hTRAILa/curcumin co-delivery to gliomas
  113. Polymeric Vector-Mediated Targeted Delivery of Anti-PAK1 siRNA to Macrophages for Efficient Atherosclerosis Treatment
  114. Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study
  115. Correction to Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem
  116. Preoperative Diagnosis of Regional Lymph Node Metastasis of Colorectal Cancer With Quantitative Parameters From Dual-Energy CT
  117. Multifunctional Nanoregulator Reshapes Immune Microenvironment and Enhances Immune Memory for Tumor Immunotherapy
  118. Solid-phase microextraction: An appealing alternative for the determination of endogenous substances - A review
  119. Can IVIM help predict HCC recurrence after hepatectomy?
  120. A robust and homogeneous porous poly(3,4-ethylenedioxythiophene)/graphene thin film for high-efficiency laser desorption/ionization analysis of estrogens in biological samples
  121. Targeted Magnetic Resonance Imaging and Modulation of Hypoxia with Multifunctional Hyaluronic Acid‐MnO 2 Nanoparticles in Glioma
  122. Tuned Cationic Dendronized Polymer: Molecular Scavenger for Rheumatoid Arthritis Treatment
  123. Mesoporous Polydopamine Carrying Manganese Carbonyl Responds to Tumor Microenvironment for Multimodal Imaging-Guided Cancer Therapy
  124. A Convenient and Versatile Amino‐Acid‐Boosted Biomimetic Strategy for the Nondestructive Encapsulation of Biomacromolecules within Metal–Organic Frameworks
  125. A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy
  126. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma
  127. Scalable fabrication of metal–phenolic nanoparticles by coordination-driven flash nanocomplexation for cancer theranostics
  128. Cationic nanoparticle as an inhibitor of cell-free DNA-induced inflammation
  129. Axillary Sentinel Lymph Nodes in Breast Cancer: Quantitative Evaluation at Dual-Energy CT
  130. Allochroic-Graphene Oxide Linked 3D Oriented Surface Imprinting Strategy for Glycoproteins Assays
  131. Assessment of Cardiac Lead Perforation: Comparison Among Chest Radiography, Transthoracic Echocardiography and Electrocardiography-gated Contrast-enhanced Cardiac CT
  132. Multifunctional Hybrid Liposome as a Theranostic Platform for Magnetic Resonance Imaging Guided Photothermal Therapy
  133. Magnetic Resonance Imaging of Bilateral Hands Is More Optimal Than MRI of Unilateral Hands for Rheumatoid Arthritis
  134. Monitoring of macrophage recruitment enhanced by Toll-like receptor 4 activation with MR imaging in nerve injury
  135. MRI-Visible siRNA Nanomedicine Directing Neuronal Differentiation of Neural Stem Cells in Stroke
  136. In vivo tracking of the tropism of mesenchymal stem cells to malignant gliomas using reporter gene-based MR imaging
  137. MR T2 value of the tibial nerve can be used as a potential non-invasive and quantitative biomarker for the diagnosis of diabetic peripheral neuropathy
  138. In Vivo Long-Term Tracking of Neural Stem Cells Transplanted into an Acute Ischemic Stroke model with Reporter Gene-Based Bimodal MR and Optical Imaging
  139. Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging
  140. The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia
  141. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer
  142. Assessment of the synergic effect of immunomodulation on nerve repair using multiparametric magnetic resonance imaging
  143. Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro
  144. Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke
  145. A novel polymeric micelle used for in vivo MR imaging tracking of neural stem cells in acute ischemic stroke
  146. Superparamagnetic Iron Oxide-Loaded Cationic Polymersomes for Cellular MR Imaging of Therapeutic Stem Cells in Stroke
  147. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI
  148. In Vivo Targeted MR Imaging of Endogenous Neural Stem Cells in Ischemic Stroke
  149. DTI metrics can be used as biomarkers to determine the therapeutic effect of stem cells in acute peripheral nerve injury
  150. Intravoxel incoherent motion MRI in differentiation between recurrent carcinoma and postchemoradiation fibrosis of the skull base in patients with nasopharyngeal carcinoma
  151. MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations
  152. Chitosan coated gold nanorod chelating gadolinium for MRI-visible photothermal therapy of cancer
  153. Predictive features of CT for risk stratifications in patients with primary gastrointestinal stromal tumour
  154. Generation of gene-target dogs using CRISPR/Cas9 system
  155. CT and MRI findings of radiation-induced external auditory canal carcinoma in patients with nasopharyngeal carcinoma after radiotherapy
  156. Prognostic CT and MR imaging features in patients with untreated extranodal non-Hodgkin lymphoma of the head and neck region
  157. CT and MR findings in 16 cases of primary neuroendocrine carcinoma in the otolaryngeal region
  158. In Vivo Targeted Magnetic Resonance Imaging of Endogenous Neural Stem Cells in the Adult Rodent Brain
  159. Insulin-producing cells from embryonic stem cells rescues hyperglycemia via intra-spleen migration
  160. Effects and Safety of Allogenic Mesenchymal Stem Cell Intravenous Infusion in Active Ankylosing Spondylitis Patients who Failed NSAIDs: A 20-Week Clinical Trial
  161. Assessment of diabetic peripheral neuropathy in streptozotocin-induced diabetic rats with magnetic resonance imaging
  162. Enhanced Repair Effect of Toll-Like Receptor 4 Activation on Neurotmesis: Assessment Using MR Neurography
  163. Radiation-induced Brachial Plexus Injury After Radiotherapy for Nasopharyngeal Carcinoma
  164. In vivo monitoring of neural stem cells after transplantation in acute cerebral infarction with dual-modal MR imaging and optical imaging
  165. Diffusion Tensor Imaging of Symptomatic Nerve Roots in Patients with Cervical Disc Herniation
  166. MR imaging and T2 measurements in peripheral nerve repair with activation of Toll-like receptor 4 of neurotmesis
  167. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma
  168. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro
  169. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: Differential diagnostic value in cervical lymphadenopathy
  170. Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem
  171. In vivo MRI monitoring nerve regeneration of acute peripheral nerve traction injury following mesenchymal stem cell transplantation
  172. Controllable labelling of stem cells with a novel superparamagnetic iron oxide–loaded cationic nanovesicle for MR imaging
  173. A Stable Focal Cerebral Ischemia Injury Model in Adult Mice: Assessment Using 7T MR Imaging
  174. Back matter
  175. Differentiation of HT22 neurons induces expression of NMDA receptor that mediates homocysteine cytotoxicity
  176. Peripheral Nerve Repair: Monitoring by Using Gadofluorine M–enhanced MR Imaging with Chitosan Nerve Conduits with Cultured Mesenchymal Stem Cells in Rat Model of Neurotmesis
  177. The clinical value of combined use of MR imaging and multi-slice spiral CT in limb salvage surgery for orthopaedic oncology patients: initial experience in nine patients
  178. Upregulation of tumor necrosis factor receptor-associated factor 6 correlated with synovitis severity in rheumatoid arthritis
  179. Intraspinal primitive neuroectodermal tumor: Imaging findings in six cases
  180. Kimura's disease: The CT and MRI characteristics in fifteen cases
  181. Synovial Infiltration with CD79a-positive B Cells, But Not Other B Cell Lineage Markers, Correlates with Joint Destruction in Rheumatoid Arthritis
  182. Transplanted Neural Stem Cells Promote Nerve Regeneration in Acute Peripheral Nerve Traction Injury: Assessment Using MRI
  183. Evaluation of cell tracking effects for transplanted mesenchymal stem cells with jetPEI/Gd-DTPA complexes in animal models of hemorrhagic spinal cord injury
  184. Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging
  185. In vivo MR imaging tracking of transplanted mesenchymal stem cells in a rabbit model of acute peripheral nerve traction injury
  186. Efficient in vitro labeling rabbit neural stem cell with paramagnetic Gd-DTPA and fluorescent substance
  187. Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide
  188. MR Neurography: T1 and T2 Measurements in Acute Peripheral Nerve Traction Injury in Rabbits
  189. Magnetic Resonance Imaging of Mesenchymal Stem Cells Labeled with Dual (MR and Fluorescence) Agents in Rat Spinal Cord Injury
  190. Bone marrow MR imaging as predictors of outcome in hemopoietic stem cell transplantation
  191. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs
  192. Magnetic resonance microneurography of rabbit sciatic nerve on a 1.5-T clinical MR system correlated with gross anatomy
  193. Retroperitoneal liposarcoma: MR characteristics and pathological correlative analysis
  194. Magnetic Resonance Imaging Findings of Temporal Lobe Radiation Encephalopathy in Nasopharyngeal Carcinoma